1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Strategy

ChromaDex Changing Name To Niagen Bioscience While Shifting Focus To Rx NAD+

 
• By Malcolm Spicer

A week after announcing 2024 full-year and fourth-quarter results, the firm says its corporate name will be Niagen Bioscience Inc. starting 19 March. It stated in its latest results that during 2024 it launched Niagen Plus line of pharmaceutical-grade Niagen.

ChromaDex rolled out Rx nicotinamide adenine dinucleotide products in August, along with a test kit for providers and consumers. (Source: CHromaDex)
Key Takeaways
  • Firm said its corporate name will be Niagen Bioscience Inc. starting on 19 March

ChromaDex Corp. is changing its name to better reflect its transition from relying on revenues from nicotinamide adenine dinucleotide (NAD+)...

More from Strategy

More from HBW Insight